Summit Therapeutics SMMT Convertible Preferred Stock Outstanding Shares
Convertible Preferred Stock Outstanding Shares at other companies
Other financials
Where this comes from
Reported directly by Summit Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.
The official record: Summit Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Summit Therapeutics's convertible preferred stock outstanding shares.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Summit Therapeutics's convertible preferred stock outstanding shares?
- Summit Therapeutics (SMMT) reported convertible preferred stock outstanding shares of 0 in Q1 2026.